361 Capital’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,785
Closed -$333K 308
2019
Q3
$333K Sell
4,785
-32
-0.7% -$2.18K 0.06% 303
2019
Q2
$339K Sell
4,817
-46
-0.9% -$3.4K 0.06% 299
2019
Q1
$399K Buy
+4,863
New +$398K 0.07% 299
2017
Q3
Sell
-39,756
Closed -$4.2M 253
2017
Q2
$4.2M Buy
39,756
+5,556
+16% +$604K 0.71% 56
2017
Q1
$3.61M Buy
+34,200
New +$3.33M 0.77% 58
2016
Q3
Sell
-979
Closed -$78K 71
2016
Q2
$78K Buy
+979
New +$71.9K 1.16% 19

Other funds holding ALB

361 Capital's ALB Position: Q4 2019 in Review

361 Capital sold out of Albemarle (ALB) in Q4 2019, closing a stake of 4,785 shares — an estimated $333K sold.

361 Capital first reported a position in ALB in Q2 2016 and held it in 6 quarters. The position peaked at $4.2M in Q2 2017. 563 funds tracked by Wall St. Rank hold ALB as of Q4 2019.

  • 361 Capital reported no remaining Albemarle position as of Q4 2019 after selling out during the quarter.
  • 361 Capital sold 4,785 Albemarle shares in Q4 2019, an estimated $333K.
  • 361 Capital first reported a position in Albemarle in Q2 2016 and held it in 6 quarters.
  • 361 Capital's Albemarle position peaked at $4.2M in Q2 2017.
  • 563 funds tracked by Wall St. Rank held Albemarle as of Q4 2019.

Based on 361 Capital's 13F filing for Q4 2019, filed 13 Feb 2020.